MIGENIX Inc. has been notified by Cutanea Life Sciences, Inc. , its development and commercialization partner for CLS001 , of the initiation of a Phase II clinical study in the treatment of rosacea.
From: biz.yahoo.com
MIGENIX Announces Initiation of Rosacea Phase II Clinical Study by Partner, Cutanea Life Sciences
Posted by Ruslan Abuzant at 7:42 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment